|
1
|
PF01784.20
|
0.83
|
5
|
4317
|
opposite-strand
|
NIF3 (NGG1p interacting factor 3)
|
|
2
|
PF04816.14
|
1.0
|
6
|
3640.5
|
opposite-strand
|
tRNA (adenine(22)-N(1))-methyltransferase
|
|
3
|
PF12847.9
|
1.0
|
6
|
3640.5
|
opposite-strand
|
Methyltransferase domain
|
|
4
|
PF13442.8
|
1.0
|
6
|
3051.5
|
opposite-strand
|
Cytochrome C oxidase, cbb3-type, subunit III
|
|
5
|
PF04539.18
|
1.0
|
6
|
1607.5
|
opposite-strand
|
Sigma-70 region 3
|
|
6
|
PF04545.18
|
1.0
|
6
|
1607.5
|
opposite-strand
|
Sigma-70, region 4
|
|
7
|
PF04542.16
|
1.0
|
6
|
1607.5
|
opposite-strand
|
Sigma-70 region 2
|
|
8
|
PF03979.16
|
1.0
|
6
|
1607.5
|
opposite-strand
|
Sigma-70 factor, region 1.1
|
|
9
|
PF00140.22
|
1.0
|
6
|
1607.5
|
opposite-strand
|
Sigma-70 factor, region 1.2
|
|
10
|
PF08275.13
|
1.0
|
6
|
-341.0
|
opposite-strand
|
DNA primase catalytic core, N-terminal domain
|
|
11
|
PF01807.22
|
1.0
|
6
|
-341.0
|
opposite-strand
|
CHC2 zinc finger
|
|
12
|
PF13155.8
|
1.0
|
6
|
-341.0
|
opposite-strand
|
Toprim-like
|
|
13
|
PF13662.8
|
1.0
|
6
|
-341.0
|
opposite-strand
|
Toprim domain
|
|
14
|
PF10410.11
|
1.0
|
6
|
-341.0
|
opposite-strand
|
DnaB-helicase binding domain of primase
|
|
15
|
PF13362.8
|
1.0
|
6
|
-341.0
|
opposite-strand
|
Toprim domain
|
|
16
|
PF01751.24
|
1.0
|
6
|
-341.0
|
opposite-strand
|
Toprim domain
|
|
17
|
PF02639.16
|
1.0
|
6
|
98.0
|
opposite-strand
|
Uncharacterized BCR, YaiI/YqxD family COG1671
|
|
18
|
PF03618.16
|
1.0
|
6
|
846.0
|
opposite-strand
|
Kinase/pyrophosphorylase
|
|
19
|
PF00571.30
|
1.0
|
6
|
1684.0
|
opposite-strand
|
CBS domain
|
|
20
|
PF08279.14
|
1.0
|
6
|
1684.0
|
opposite-strand
|
HTH domain
|
|
21
|
PF01047.24
|
1.0
|
6
|
1684.0
|
opposite-strand
|
MarR family
|
|
22
|
PF02092.19
|
1.0
|
6
|
2456.0
|
opposite-strand
|
Glycyl-tRNA synthetase beta subunit
|
|
23
|
PF02091.17
|
0.83
|
5
|
4488
|
opposite-strand
|
Glycyl-tRNA synthetase alpha subunit
|